Janux Therapeutics unveiled promising results for a prostate cancer treatment on Tuesday, and the biotech stock nearly tripled. The post Janux Stock Launches…
Janux Therapeutics (NASDAQ:JANX – Get Free Report)‘s stock had its “outperform” rating reiterated by William Blair in a research report issued on Tuesday, RTT News reports. Several other brokerages also recently commented on JANX. Wedbush upped their price objective on Janux Therapeutics from $24.00 to $53.00 and gave the company an “outperform” rating in a […]
JANX stock is up on interim study results Janux Therapeutics (NASDAQ:JANX) stock is rocketing higher on Tuesday after the clinical-stage biopharmaceutical…
Janux Therapeutics Announces Proposed Public Offering of Common Stock streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.